A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback. (February 2019)
- Record Type:
- Journal Article
- Title:
- A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback. (February 2019)
- Main Title:
- A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback
- Authors:
- Liu, Jintong
Du, Ping
Liu, Tianrui
Córdova Wong, Bernardino J.
Wang, Weiping
Ju, Huangxian
Lei, Jianping - Abstract:
- Abstract: Selecting the timing of laser treatment is an important task for improving O2 -dependent photodynamic therapy (PDT) efficiency. Here, a black phosphorus-based strategy was developed for dual-mode monitoring oxygen self-supply, enhancing photodynamic therapy, and feeding back therapeutic effect. The hybridized nanoplatform (R-MnO2 -FBP) was prepared by assembly of Rhodamine B (RhB)-encapsulated manganese dioxide (R-MnO2 ) as O2 supplier and indicator, and fluorescein isothiocyanate (FITC)-labelled peptide-functionalized black phosphorus as the theranostic agent. The time-dependent assays suggested that the O2 release was proportional to the liberation of Mn 2+ and RhB in the R-MnO2 -FBP system. After specific delivery into cancer cells, R-MnO2 -FBP was dissociated in the acidic and H2 O2 -rich environment and generated oxygen to overcome hypoxia-associated PDT resistance. In the meantime, it released both Mn 2+ and RhB dye, leading to dual-mode (magnetic resonance imaging/fluorescence imaging) monitoring of the oxygen self-supply process. More significantly, the imaging-guided PDT in hypoxic cells displayed 51.6% of cell apoptosis at optimizing timing of laser application, which could also be confirmed by the FITC fluorescence recovery induced by the activated caspase-3 in apoptotic cells. In vivo photonic therapy by R-MnO2 -FBP further demonstrated the ability of R-MnO2 -FBP to choose the timing of laser application, providing an efficient approach for theAbstract: Selecting the timing of laser treatment is an important task for improving O2 -dependent photodynamic therapy (PDT) efficiency. Here, a black phosphorus-based strategy was developed for dual-mode monitoring oxygen self-supply, enhancing photodynamic therapy, and feeding back therapeutic effect. The hybridized nanoplatform (R-MnO2 -FBP) was prepared by assembly of Rhodamine B (RhB)-encapsulated manganese dioxide (R-MnO2 ) as O2 supplier and indicator, and fluorescein isothiocyanate (FITC)-labelled peptide-functionalized black phosphorus as the theranostic agent. The time-dependent assays suggested that the O2 release was proportional to the liberation of Mn 2+ and RhB in the R-MnO2 -FBP system. After specific delivery into cancer cells, R-MnO2 -FBP was dissociated in the acidic and H2 O2 -rich environment and generated oxygen to overcome hypoxia-associated PDT resistance. In the meantime, it released both Mn 2+ and RhB dye, leading to dual-mode (magnetic resonance imaging/fluorescence imaging) monitoring of the oxygen self-supply process. More significantly, the imaging-guided PDT in hypoxic cells displayed 51.6% of cell apoptosis at optimizing timing of laser application, which could also be confirmed by the FITC fluorescence recovery induced by the activated caspase-3 in apoptotic cells. In vivo photonic therapy by R-MnO2 -FBP further demonstrated the ability of R-MnO2 -FBP to choose the timing of laser application, providing an efficient approach for the enhancement of PDT process. Graphical abstract: A multifunctional black phosphorus was designed as all-in-one theranostic nanoplatform for cancer-cell target delivery, dual-modal tracking of the pH/H2 O2 responsive oxygen supply, photodynamic therapy enhancement, and feeding back therapeutic efficacy in real time. Image 1 Highlights: Black phosphorus-based theranostic system is developed for enhanced PDT. Dual-modal tracking of oxygen supply guides the timing of laser application. A self-feedback system is established for the therapeutic response in real time. All-in-one theranostic platform is achieved with whole-process self-tracking. … (more)
- Is Part Of:
- Biomaterials. Volume 192(2019)
- Journal:
- Biomaterials
- Issue:
- Volume 192(2019)
- Issue Display:
- Volume 192, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 192
- Issue:
- 2019
- Issue Sort Value:
- 2019-0192-2019-0000
- Page Start:
- 179
- Page End:
- 188
- Publication Date:
- 2019-02
- Subjects:
- Biosensors -- Black phosphorus -- Manganese dioxide -- Fluorescent probes -- Photodynamic therapy -- Oxygen self-supply
Biomedical materials -- Periodicals
Biocompatible Materials -- Periodicals
Biomatériaux -- Périodiques
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01429612 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01429612 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01429612 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.biomaterials.2018.10.018 ↗
- Languages:
- English
- ISSNs:
- 0142-9612
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.715000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21517.xml